patients with diagnosed lower-extremity DVT ( therapeutic branch , n = @ ) and patients requiring venous thromboembolism ( VTE ) prophylaxis after arterial vascular surgery or major lower-extremity amputations ( prophylactic branch , n = @ ) were randomized to receive generic or branded enoxaparin for up to seven days .